Production (Stage)
D
Vigil Neuroscience, Inc. VIGL
$7.89 $0.010.13% NASDAQ
Recommendation
Prev Close
$7.89
Volume
3,706,079
Avg Vol (90D)
1,161,194
Market Cap
$368.24M
Dividend & Yield
--
52-Week Range
$1.31 - $7.95
P/E (TTM)
--
EPS (TTM)
-$2.06
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
JMP Securities Reaffirms Market Perform Rating for Vigil Neuroscience (NASDAQ:VIGL)
5/24/2025 - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders
5/24/2025 - Globe Newswire
Vigil Neuroscience (VIGL, $7.89) entered Uptrend as Momentum indicator ascends above 0 level on May 23, 2025
5/24/2025 - Tickeron - Stocks
Vigil Neuroscience (NASDAQ:VIGL) Downgraded by William Blair to Hold
5/24/2025 - MarketBeat
Vigil Neuroscience (NASDAQ:VIGL) Cut to "Hold" at Wedbush
5/24/2025 - MarketBeat
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
5/24/2025 - Globe Newswire
Vigil Neuroscience Elects Directors at Annual Meeting
5/23/2025 - TipRanks Financial Blog
Wall Street Analysts Believe Vigil Neuroscience (VIGL) Could Rally 86.68%: Here's is How to Trade
5/23/2025 - Zacks Investment Research
Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
5/23/2025 - Zacks Investment Research
Vigil Neuroscience (VIGL, $2.31) entered Uptrend as Momentum indicator ascends above 0 level on May 22, 2025
5/23/2025 - Tickeron - Stocks
Vigil Neuroscience (VIGL) Downgraded by Mizuho After Sanofi Acquisition VIGL Stock News
5/23/2025 - GuruFocus
Vigil Neuroscience just downgraded at Mizuho, here's why
5/23/2025 - The Fly
JMP Securities Reaffirms "Market Perform" Rating for Vigil Neuroscience (NASDAQ:VIGL)
5/23/2025 - Ticker Report
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & ...
5/22/2025 - GuruFocus
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL
5/22/2025 - Business Wire
Vigil Neuroscience just downgraded at Jefferies, here's why
5/22/2025 - The Fly
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
5/22/2025 - Investopedia Headlines
Vigil Neuroscience (VIGL) Downgraded to Market Perform by JMP Securities VIGL Stock News
5/22/2025 - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, TXNM, SVT, PTIX on Behalf of Shareholders
5/22/2025 - PR Newswire
Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout
5/22/2025 - Zacks Investment Research
Morning Brew: Sanofi Acquires Vigil Neuroscience, Walmart Restructures
5/22/2025 - GuruFocus
Wedbush Downgrades Vigil Neuroscience (VIGL), Price Target Lowered VIGL Stock News
5/22/2025 - GuruFocus
Shareholder Alert: The Ademi Firm Investigates Whether Vigil Neuroscience Inc. ...
5/22/2025 - GuruFocus
Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish
5/22/2025 - Stocktwits News Feed
Shareholder Alert: The Ademi Firm Investigates Whether Vigil Neuroscience Inc. Is Obtaining a Fair Price for Its Public Shareholders
5/22/2025 - Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$91.27M
EBIT (TTM)
-$91.74M
Net Income (TTM)
-$86.73M
Balance Sheet
Total Assets (Q)
$107.15M
Total Debt (Q)
$12.69M
Total Liabilities (Q)
$42.03M
Book Value Per Share (Q)
$1.40
Cash Flow
Cash from Operations (TTM)
-$53.24M
Cash from Investing (TTM)
$15.52M
Cash from Financing (TTM)
$37.57M
Net Change in Cash (TTM)
-$141.00K
Filings
Filing Date
Wednesday, May 7, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
0.33
7-Day Total Return
240.09%
30-Day Total Return
429.53%
60-Day Total Return
226.03%
90-Day Total Return
310.94%
Year to Date Total Return
345.76%
1-Year Total Return
117.36%
2-Year Total Return
-21.02%
3-Year Total Return
189.01%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $1.31
52-week High
May 22, 2025 - $7.95
Valuation
Market Cap
$368.24M - Small Cap
Enterprise Value
$293.83M
Price/Sales (TTM)
--
Price/Book (Q)
5.65
Dividends and Shares
Shares Outstanding
46.07M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vigilneuro.com
Phone Number
857 254 4445
Address
100 Forge Road
Suite 700 - Watertown
Watertown, MA 02472
Country
United States
Year Founded
2020
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the... more
NASDAQ 05/23/2025 4:00PM Eastern Quotes delayed